Cassava Sciences

$36.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$5.42 (-13.04%) As of 7:03 PM UTC today

Why Robinhood?

You can buy or sell SAVA and other stocks, options, and ETFs commission-free!

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.

CEO
Remi Barbier
Employees
11
Headquarters
Austin, Texas
Founded
1998
Market Cap
1.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.38M
High Today
$41.05
Low Today
$36.05
Open Price
$41.05
Volume
2.03M
52 Week High
$117.54
52 Week Low
$1.63

SAVA Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, Pre-Market

You May Also Like

RC-B
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure